US2004091605A1PendingUtilityA1

Method of coating a stent with a polysaccharide layer and associated stents

Assignee: BIOTRONIK MESS & THERAPIEGPriority: May 24, 2002Filed: May 23, 2003Published: May 13, 2004
Est. expiryMay 24, 2022(expired)· nominal 20-yr term from priority
Y10S623/90A61L 31/10Y10T428/31536A61L 2420/02Y10S623/901A61F 2/82
29
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention concerns methods of coating stents and stents produced in accordance therewith. The object of the invention is to provide methods of coating stents with a polysaccharide layer which has improved adhesion capacity on the substrate surface of the implant, and to afford correspondingly functionalized stents. That is achieved inter alia by covalent bonding of a non-crosslinked hyaluronic acid to a substrate surface of the stent with the formation of hyaluronic acid layer and crosslinking of the hyaluronic acid layer.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method of coating a surface of a stent with a polysaccharide layer, the method comprising the steps of: 
 providing a stent with a surface prepared for covalent bonding of a polysaccharide thereto; and    bonding a non-crosslinked polysaccharide covalently to the prepared surface, thereby providing a polysaccharide surface layer.    
     
     
         2 . The method of  claim 1 , comprising the further step of: 
 forming a cross-linked polysaccharide outer layer.    
     
     
         3 . The method of  claim 2 , wherein: 
 the non-crosslinked polysaccharide is hyaluronic acid; and    the crosslinked polysaccharide outer layer is formed by crosslinking the polysaccharide surface layer.    
     
     
         4 . The method of  claim 3 , wherein: 
 the step of providing the stent with a surface prepared for covalent bonding comprises bonding a bonding agent layer to the substrate surface.    
     
     
         5 . The method of  claim 2 , wherein: 
 the non-crosslinked polysaccharide is hyaluronic acid; and    the crosslinked polysaccharide outer layer is formed by covalently bonding a layer of a crosslinked hyaluronic acid to the polysaccharide surface layer.    
     
     
         6 . The method of  claim 2 , wherein: 
 the non-crosslinked polysaccharide is hyaluronic acid; and    the crosslinked polysaccharide outer layer is formed by the steps of covalently bonding a layer of a non-crosslinked hyaluronic acid to the polysaccharide surface layer and crosslinking the non-crosslinked hyaluronic acid layer.    
     
     
         7 . The method of  claim 1 , wherein: 
 the step of providing the stent with a surface prepared for covalent bonding comprises bonding a bonding agent layer to the substrate surface; and    the step of bonding a non-crosslinked polysaccharide covalently to the prepared surface is accomplished by the steps of: 
 bonding a non-crosslinked chitosan covalently to the bonding agent; and  
 bonding a layer of crosslinked hyaluronic acid covalently to the chitosan.  
   
     
     
         8 . The method of  claim 1 , wherein: 
 the step of providing the stent with a surface prepared for covalent bonding comprises bonding a bonding agent layer to the substrate surface; and    the step of bonding a non-crosslinked polysaccharide covalently to the prepared surface is accomplished by the steps of: 
 bonding a non-crosslinked chitosan covalently to the bonding agent; and  
 bonding a layer of non-crosslinked hyaluronic acid covalently to the chitosan.  
   
     
     
         9 . A stent, comprising a polysaccharide surface layer applied by the method of  claim 1.

Join the waitlist — get patent alerts

Track US2004091605A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.